---
figid: PMC6938582__nihms-1535539-f0002
figlink: pmc/articles/PMC6938582/figure/F2/
number: F2
caption: 'Mechanism of action of metformin in endocrine tumors: metformin is a negatively
  charged molecule that enters the cell through organic cation transporters (OCTs).
  After entering the cells, it can inhibit tumorigenesis through the following pathways.
  First, metformin, through its direct action, can inhibit complex 1 or mGPDH, either
  alone or together, to inhibit oxidative phosphorylation (OXPHOS). This inhibition
  of OXPHOS lowers the energy production (ATP synthesis) within the cells, which creates
  cellular stress in cancer cells. The reduction in ATP production increases both
  the AMP:ATP and ADP:ATP ratios, which activates AMPK. Activation of AMPK, in turn,
  leads to activation of tuberous sclerosis complex ½ (TSC ½), which inhibits the
  mTOR pathway. Second, metformin can inhibit insulin or insulin-like growth factor-1
  (IGF-1) mediated activation of the RAS-MEK-ERK and PI3K-AKT pathways, which results
  in the inhibition of the mTOR pathway. Third, metformin-mediated activation of AMPK
  can inhibit phosphorylation of insulin receptor substrate-1 (IRS-1). IRS-1 is downstream
  of the IGF-1 pathway and upstream of the PI3K-AKT pathway. Inhibition of IRS-1 activity
  hampers AKT phosphorylation, which causes activation of the TSC complex and inhibition
  of the mTOR pathway. Last, metformin has other targets including STAT3, GSK3, and
  ATF3 in endocrine cells, but the exact pathway by which metformin targets these
  genes/proteins are not known.'
pmcid: PMC6938582
papertitle: The Role of an Antidiabetic Drug – Metformin – in the Treatment of Endocrine
  Tumors.
reftext: Shilpa Thakur, et al. J Mol Endocrinol. ;63(2):R17-R35.
pmc_ranked_result_index: '1708'
pathway_score: 0.9786918
filename: nihms-1535539-f0002.jpg
figtitle: 'Action of metformin in endocrine tumors: metformin is a negatively charged
  molecule that enters the cell through organic cation transporters (OCTs)'
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6938582__nihms-1535539-f0002.html
  '@type': Dataset
  description: 'Mechanism of action of metformin in endocrine tumors: metformin is
    a negatively charged molecule that enters the cell through organic cation transporters
    (OCTs). After entering the cells, it can inhibit tumorigenesis through the following
    pathways. First, metformin, through its direct action, can inhibit complex 1 or
    mGPDH, either alone or together, to inhibit oxidative phosphorylation (OXPHOS).
    This inhibition of OXPHOS lowers the energy production (ATP synthesis) within
    the cells, which creates cellular stress in cancer cells. The reduction in ATP
    production increases both the AMP:ATP and ADP:ATP ratios, which activates AMPK.
    Activation of AMPK, in turn, leads to activation of tuberous sclerosis complex
    ½ (TSC ½), which inhibits the mTOR pathway. Second, metformin can inhibit insulin
    or insulin-like growth factor-1 (IGF-1) mediated activation of the RAS-MEK-ERK
    and PI3K-AKT pathways, which results in the inhibition of the mTOR pathway. Third,
    metformin-mediated activation of AMPK can inhibit phosphorylation of insulin receptor
    substrate-1 (IRS-1). IRS-1 is downstream of the IGF-1 pathway and upstream of
    the PI3K-AKT pathway. Inhibition of IRS-1 activity hampers AKT phosphorylation,
    which causes activation of the TSC complex and inhibition of the mTOR pathway.
    Last, metformin has other targets including STAT3, GSK3, and ATF3 in endocrine
    cells, but the exact pathway by which metformin targets these genes/proteins are
    not known.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - STAT3
  - HRAS
  - KRAS
  - NRAS
  - IRS1
  - GSK3A
  - GSK3B
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - EGFR
  - AKT2
  - AKT3
  - AKT1
  - ATF3
  - MFAP1
  - MAP2K1
  - MAP2K2
  - WDTC1
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - MAPK3
  - MAPK1
  - TSC1
  - TSC2
  - RPS6KB1
  - RPS6KB2
  - AMP
  - ATP
  - ADP
genes:
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: --|STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ATF3
  symbol: ATF3
  source: hgnc_symbol
  hgnc_symbol: ATF3
  entrez: '467'
- word: 'АMP:'
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
chemicals:
- word: AMP
  source: MESH
  identifier: D000249
- word: ATP
  source: MESH
  identifier: D000255
- word: ADP
  source: MESH
  identifier: D000244
diseases: []
figid_alias: PMC6938582__F2
redirect_from: /figures/PMC6938582__F2
figtype: Figure
---
